Nanoform raises its mid-term business targets for 2025
Insider information Nanoform Finland Plc June 2, 2021 04:00 p.m. Finnish time / 03:00 p.m. Swedish time Nanoform raises its mid-term business targets for 2025 Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced its raised mid-term business targets for 2025. The new targets are as follows: · To nanoform annually at least 70 new active pharmaceutical ingredients, or ‘APIs’ (40% increase from the previous target of at least 50 new APIs annually) · To have in place 35 operating production lines, of